Treovir
Bala Cynwyd, US · Founded 2019 · Delaware LLC
Founders & leadership
GY
G. Yancey GillespieNamed on SEC filing
MC
Michael ChristiniNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$287K disclosed across 1 round · 2019
▶$287KraisedSep 2021 · 6 investors · BiotechnologyRule 506(b)
▶$287KraisedSep 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- G. Yancey GillespieExecutive Officer, Director
- Michael ChristiniExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $287K
- First sale
- Dec 2019
- Incorporated
- Limited Liability Company, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Treovir raised?
- Treovir has disclosed $287K raised across 1 round.
- Where is Treovir headquartered?
- Treovir is headquartered in Bala Cynwyd, US.